161 related articles for article (PubMed ID: 27011261)
1. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Phloroglucinol, A Component of Ecklonia cava Extract, on Hepatic Glucose Production.
Yoon JY; Choi H; Jun HS
Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28379184
[TBL] [Abstract][Full Text] [Related]
3. Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis.
Chen Y; Li Q; Zhao S; Sun L; Yin Z; Wang X; Li X; Iwakiri Y; Han J; Duan Y
Biochem Pharmacol; 2023 Dec; 218():115928. PubMed ID: 37979703
[TBL] [Abstract][Full Text] [Related]
4. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model.
Choi HE; Kim Y; Lee HJ; Cheon HG
Eur J Pharmacol; 2021 May; 899():174011. PubMed ID: 33705803
[TBL] [Abstract][Full Text] [Related]
5. Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study.
Gupta M; Rumman M; Singh B; Mahdi AA; Pandey S
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1647-1658. PubMed ID: 37704773
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Cholesterol Sulfotransferase SULT2B1b by Hepatocyte Nuclear Factor 4α Constitutes a Negative Feedback Control of Hepatic Gluconeogenesis.
Bi Y; Shi X; Zhu J; Guan X; Garbacz WG; Huang Y; Gao L; Yan J; Xu M; Ren S; Ren S; Liu Y; Ma X; Li S; Xie W
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29378829
[TBL] [Abstract][Full Text] [Related]
7. Hepatic estrogen receptor α is critical for regulation of gluconeogenesis and lipid metabolism in males.
Qiu S; Vazquez JT; Boulger E; Liu H; Xue P; Hussain MA; Wolfe A
Sci Rep; 2017 May; 7(1):1661. PubMed ID: 28490809
[TBL] [Abstract][Full Text] [Related]
8. PEPCK-M expression in mouse liver potentiates, not replaces, PEPCK-C mediated gluconeogenesis.
Méndez-Lucas A; Duarte JA; Sunny NE; Satapati S; He T; Fu X; Bermúdez J; Burgess SC; Perales JC
J Hepatol; 2013 Jul; 59(1):105-13. PubMed ID: 23466304
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α.
Shi X; Cheng Q; Xu L; Yan J; Jiang M; He J; Xu M; Stefanovic-Racic M; Sipula I; O'Doherty RM; Ren S; Xie W
Mol Cell Biol; 2014 Feb; 34(3):485-97. PubMed ID: 24277929
[TBL] [Abstract][Full Text] [Related]
10. Cold acclimation reduces hepatic protein Kinase B and AMP-activated protein kinase phosphorylation and increases gluconeogenesis in Rats.
Sepa-Kishi DM; Katsnelson G; Bikopoulos G; Iqbal A; Ceddia RB
Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29504286
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high-fat diet-fed mice.
Jing Y; Sun Q; Xiong X; Meng R; Tang S; Cao S; Bi Y; Zhu D
J Diabetes Investig; 2019 Mar; 10(2):251-260. PubMed ID: 30070033
[TBL] [Abstract][Full Text] [Related]
12. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X
J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209
[TBL] [Abstract][Full Text] [Related]
13. Anti-adipogenic effect of the flavonoids through the activation of AMPK in palmitate (PA)-treated HepG2 cells.
Rajan P; Natraj P; Ranaweera SS; Dayarathne LA; Lee YJ; Han CH
J Vet Sci; 2022 Jan; 23(1):e4. PubMed ID: 35088951
[TBL] [Abstract][Full Text] [Related]
14. Berberine-silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism.
Ma X; Yu X; Li R; Cui J; Yu H; Ren L; Jiang J; Zhang W; Wang L
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117238. PubMed ID: 37774895
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor HNF-4α: a key player in haematological disorders.
Belali T; Abomughaid M; Alhujaily M
Arch Med Sci; 2023; 19(6):1646-1652. PubMed ID: 38058729
[TBL] [Abstract][Full Text] [Related]
16. FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection.
Karanth S; Chaurasia B; Bowman FM; Tippetts TS; Holland WL; Summers SA; Schlegel A
Physiol Rep; 2019 Sep; 7(18):e14238. PubMed ID: 31552709
[TBL] [Abstract][Full Text] [Related]
17. The hepatic compensatory response to elevated systemic sulfide promotes diabetes.
Carter RN; Gibbins MTG; Barrios-Llerena ME; Wilkie SE; Freddolino PL; Libiad M; Vitvitsky V; Emerson B; Le Bihan T; Brice M; Su H; Denham SG; Homer NZM; Mc Fadden C; Tailleux A; Faresse N; Sulpice T; Briand F; Gillingwater T; Ahn KH; Singha S; McMaster C; Hartley RC; Staels B; Gray GA; Finch AJ; Selman C; Banerjee R; Morton NM
Cell Rep; 2021 Nov; 37(6):109958. PubMed ID: 34758301
[TBL] [Abstract][Full Text] [Related]
18. Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1- and G6PC-mediated gluconeogenesis.
Yang H; Su M; Liu M; Sheng Y; Zhu L; Yang L; Mu R; Zou J; Liu X; Liu L
Acta Pharm Sin B; 2023 Sep; 13(9):3728-3743. PubMed ID: 37719384
[TBL] [Abstract][Full Text] [Related]
19. HM-chromanone isolated from
Park JE; Han JS
Toxicol Res (Camb); 2023 Aug; 12(4):648-657. PubMed ID: 37663815
[TBL] [Abstract][Full Text] [Related]
20. Modulation Effects of
Xie X; Chen C; Fu X
Foods; 2023 Dec; 12(24):. PubMed ID: 38137213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
